Results 71 to 80 of about 1,476 (103)

Risk of Switch to Mania/Hypomania in Bipolar Depressive Patients Treated with Antidepressants: A Real-World Study. [PDF]

Health Data Sci
Feng L, Wang W, Yin C, Li J, Zhang X, Chang X, Feng Z, Van Zandt M, You SC, Seager S, Reich C, Zhan S, Sun F, Wang G.   +13 more
europepmc   +1 more source

The effect of sleep-wake behaviors on the onset of mania in youth: A computational model. [PDF]

Eur Psychiatry
Glavatskiy K, Hickie IB, Crouse JJ, Capon W, Prodan A, Scott J, Merikangas K, Carpenter JS, Varidel M, Scott EM, Iorfino F.   +10 more
europepmc   +1 more source

Rational antipsychotic polypharmacy in psychotic and bipolar disorders: A focus on D2 receptor partial agonists. [PDF]

Ment Health Clin
Salwan A.
europepmc   +1 more source

Suicide Deaths in People With Bipolar Disorder: Characteristics and Treatments at Time of Death. [PDF]

Bipolar Disord
Schaffer A, Chan PPM, Men VY, Steinberg R, Mitchell RH, Malhi G, Yatham LN, Sinyor M.   +7 more
europepmc   +1 more source

Do Patients Comply With 12-h Lithium Blood Level Timing? Findings From a Controlled Clinical Trial and a Real-World Clinical Setting. [PDF]

Bipolar Disord
Jacobsen SL, Kraft CL, Nierenberg AA, Devantier TA, Köhler-Forsberg O.   +4 more
europepmc   +1 more source

Sex-informed estrogen receptor modulation in schizophrenia: a male-focused ERβ/GPER1 framework for cognitive and negative symptoms. [PDF]

Front Psychiatry
Carlson J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Depressive mania associated with nonresponse to antimanic agents

American Journal of Psychiatry, 1993
Of 39 patients consecutively admitted for the treatment of primary mania, 21 (53.8%) simultaneously met the Research Diagnostic Criteria for major depressive disorder ("mixed" or "depressive" mania). Only nine (42.9%) of the 21 patients with depressive mania responded to antimanic agents.
Alan Swann, S C Dilsaver
exaly   +4 more sources

The Ascendancy of Second-Generation Antipsychotics as Frontline Antimanic Agents

Journal of Clinical Psychopharmacology, 2015
Knowledge of the factors affecting the adoption of new medications can enhance mental health care and guide quality improvement and policy development. Food and Drug Administration indications for treating bipolar disorder with several second-generation antipsychotics (SGAs) in the 2000s represent an opportunity to identify factors that impact the ...
Samuel Nordberg, Christopher Miller, Eric G Smith   +2 more
exaly   +3 more sources